| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Medicine, University of Minnesota, Minneapolis, MN, USA
2 Nutritional Science, Okayama Prefectural University, Okayama, Soja, Japan
* To whom correspondence should be addressed. E-mail: chenx106{at}umn.edu.
Congestive heart failure (CHF) is associated with impaired endothelium-dependent nitric oxide (NO) mediated vasodilation (endothelial dysfunction). We hypothesized that coronary endothelial dysfunction in CHF may be due in part to decreased dimethylarginine dimethylaminohydrolase (DDAH), the enzyme that degrades endogenous inhibitors of NOS, including asymmetric dimethylarginine (ADMA). Coronary blood flow and the endothelium-dependent vasodilator response to acetylcholine were studied in dogs in which CHF was produced by rapid ventricular pacing for 4 weeks. Coronary flow and MVO2 at rest and during treadmill exercise were decreased after development of CHF, and the vasodilator response to acetylcholine (75 µg/min intracoronary) was decreased by 39±5%. DDAH activity and DDAH isoform 2 (DDAH2) protein content were decreased by 53 ±13 % and 58±14 %, respectively, in hearts with CHF, while eNOS and DDAH isoform 1 (DDAH1) were increased. Caveolin-1 and protein arginine N-methyltransferase I (PRMT1), the enzyme that produces ADMA, were unchanged. Immunohistochemical staining showed DDAH1 strongly expressed in coronary endothelium and smooth muscle, and in the sarcolemma of cardiac myocytes. In cultured human endothelial cells DDAH1 was uniformly distributed in the cytosol and nucleus, while DDAH2 was found only in the cytosol. Decreased DDAH activity and DDAH2 protein expression may cause accumulation of endogenous inhibitors of eNOS, thereby contributing to endothelial dysfunction in the failing heart.
This article has been cited by other articles:
|
|
 |
|
  W. H. Wilson Tang, W. Tong, K. Shrestha, Z. Wang, B. S. Levison, B. Delfraino, B. Hu, R. W. Troughton, A. L. Klein, and S. L. Hazen Differential effects of arginine methylation on diastolic dysfunction and disease progression in patients with chronic systolic heart failure Eur. Heart J., October 2, 2008; 29(20): 2506 - 2513. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. J. Pope, L. Druhan, J. E. Guzman, S. P. Forbes, V. Murugesan, D. Lu, Y. Xia, L. G. Chicoine, N. L. Parinandi, and A. J. Cardounel Role of DDAH-1 in lipid peroxidation product-mediated inhibition of endothelial NO generation Am J Physiol Cell Physiol, November 1, 2007; 293(5): C1679 - C1686. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Hasegawa, S. Wakino, S. Tatematsu, K. Yoshioka, K. Homma, N. Sugano, M. Kimoto, K. Hayashi, and H. Itoh Role of Asymmetric Dimethylarginine in Vascular Injury in Transgenic Mice Overexpressing Dimethylarginie Dimethylaminohydrolase 2 Circ. Res., July 20, 2007; 101(2): e2 - e10. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Zhang, X. Xu, X. Hu, E. D. van Deel, G. Zhu, and Y. Chen Inducible Nitric Oxide Synthase Deficiency Protects the Heart From Systolic Overload-Induced Ventricular Hypertrophy and Congestive Heart Failure Circ. Res., April 13, 2007; 100(7): 1089 - 1098. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Iida, Y. Chu, R. M. Weiss, Y. M. Kang, F. M. Faraci, and D. D. Heistad Vascular effects of a common gene variant of extracellular superoxide dismutase in heart failure Am J Physiol Heart Circ Physiol, August 1, 2006; 291(2): H914 - H920. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Hasegawa, S. Wakino, T. Tanaka, M. Kimoto, S. Tatematsu, T. Kanda, K. Yoshioka, K. Homma, N. Sugano, M. Kurabayashi, et al. Dimethylarginine Dimethylaminohydrolase 2 Increases Vascular Endothelial Growth Factor Expression Through Sp1 Transcription Factor in Endothelial Cells Arterioscler Thromb Vasc Biol, July 1, 2006; 26(7): 1488 - 1494. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |
